Startup profile for Coral Care: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Coral Care funding, valuation and investors

In-home pediatric speech, OT, and PT therapy platform with clinician practice tools.

Keep track of Coral Care

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series A

$13M · February 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$13M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series a · New York, NY

Investors in latest funding

Lead: Haymaker Ventures

Other: Charge Ventures

Sources: latest funding Last verified: 2026-07-25

Overview

Coral Care connects families with licensed pediatric therapists for insurance-covered in-home speech, occupational, and physical therapy while giving clinicians credentialing, scheduling, documentation, and billing infrastructure. Founded by Jen Wirt, the NYC company raised $13M Series A in February 2026 led by Haymaker Ventures; Charge Ventures participated alongside AlleyCorp, Reach Capital, and others. Coral Care operates across Massachusetts, New Hampshire, Texas, Illinois, and Pennsylvania with recent launches in Dallas, Houston, Chicago, Philadelphia, and Pittsburgh.

Why Coral Care is interesting

Pediatric therapy waitlists are brutal — Coral Care's dual-sided model adds provider supply by giving therapists a private-practice-in-a-box while parents get in-home access.

Product & use cases

Marketplace plus vertical ops stack for in-home pediatric developmental therapy with insurance billing and clinician enablement.

  • In-home speech therapy for children
  • Occupational/physical therapy with insurance coverage
  • Therapists running flexible private practices via Coral infrastructure

Key facts

  • Series A (Feb 2026): $13M led by Haymaker
  • Charge Ventures follow-on from 2024 seed
  • Founded 2023 by Jen Wirt
  • Multi-state in-home pediatric therapy footprint

Funding history (newest first)

Investors in our directory

Funds linked from Coral Care's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Insurance-covered in-home model with integrated credentialing/billing — harder than pure cash-pay teletherapy plays.

Pediatric therapy supply constraints create demand, but insurance billing complexity kills many startups. Coral must prove unit economics as it expands state-by-state with payer contracts.

  • Brightline / teletherapy pediatric adjacent

    Virtual pediatric mental health; less in-home OT/PT focus.

  • Local therapy clinics incumbent

    Brick-and-mortar waitlists Coral targets to bypass.

  • Early intervention agencies incumbent

    State-funded programs with long intake delays.

Notable stories

  • Charge Ventures backed Coral Care's Series A as a follow-on to its 2024 investment per VCT coverage.

Industries

Healthtech Consumer

Related funding articles

Venture Capital Tracker pieces that cover Coral Care's financing or category context.

FAQs about Coral Care

Practical answers founders, operators, and investors typically search for.

In-home pediatric speech, occupational, and physical therapy with insurance billing and clinician tools.
Haymaker led Series A; Charge Ventures participated. See /fund/charge-ventures.
$13M Series A in February 2026.
MA, NH, TX, IL, PA and expanding cities including Dallas, Houston, Chicago, Philadelphia, Pittsburgh.
No — focuses on in-home, insurance-covered therapy visits.
Jen Wirt in 2023.
Brings therapists to the home and supplies back-office infrastructure for independent clinicians.
Charge is Brooklyn pre-seed/seed; Coral is a follow-on healthcare bet.
Private; not disclosed.
Works with insurance-covered services; specific payer lists on joincoralcare.com.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.